AAAAAA

   
Results: 1-11 |
Results: 11
IFOSFAMIDE AND VINORELBINE - AN ACTIVE REGIMEN FOR PATIENTS WITH RELAPSED OR REFRACTORY HODGKINS-DISEASE
Authors: BONFANTE V VIVIANI S SANTORO A DEVIZZI L DIRUSSO A ZANINI M SONCINI F PARRA HS VALAGUSSA P BONADONNA G
Citation: V. Bonfante et al., IFOSFAMIDE AND VINORELBINE - AN ACTIVE REGIMEN FOR PATIENTS WITH RELAPSED OR REFRACTORY HODGKINS-DISEASE, British Journal of Haematology, 103(2), 1998, pp. 533-535
ACCEPTABILITY OF FOLLOW-UP VISITS (FU) IN LONG-TERM SURVIVORS FROM HODGKINS-DISEASE (HD)
Authors: MENCAGLIA E BONFANTE V VIVIANI S PARRA HS SANTORO A
Citation: E. Mencaglia et al., ACCEPTABILITY OF FOLLOW-UP VISITS (FU) IN LONG-TERM SURVIVORS FROM HODGKINS-DISEASE (HD), European journal of cancer, 33, 1997, pp. 266-266
4 CYCLES OF ABVD FOLLOWED BY INVOLVED FIELD IRRADIATION (IF-RT) IS THE TREATMENT OF CHOICE FOR EARLY-STAGE HODGKINS-DISEASE (HD) - 5-YEAR RESULTS OF A RANDOMIZED TRIAL
Authors: SANTORO A BONFANTE V VIVIANI S ZANINI M DEVIZZI L PARRA HS DIRUSSO A SONCINI F VILLANI F VALAGUSSA P BONADONNA G
Citation: A. Santoro et al., 4 CYCLES OF ABVD FOLLOWED BY INVOLVED FIELD IRRADIATION (IF-RT) IS THE TREATMENT OF CHOICE FOR EARLY-STAGE HODGKINS-DISEASE (HD) - 5-YEAR RESULTS OF A RANDOMIZED TRIAL, European journal of cancer, 33, 1997, pp. 1185-1185
INTERMEDIATE-HIGH DOSE SEQUENTIAL SINGLE-AGENT CHEMOTHERAPY COMBINED WITH IRRADIATION IN ADVANCED HODGKINS-DISEASE (HD)
Authors: BONFANTE V BONADONNA G SANTORO A VIVIANI S DEVIZZI L PARRA HS ZANINI M DIRUSSO A VILLANI F VALAGUSSA P
Citation: V. Bonfante et al., INTERMEDIATE-HIGH DOSE SEQUENTIAL SINGLE-AGENT CHEMOTHERAPY COMBINED WITH IRRADIATION IN ADVANCED HODGKINS-DISEASE (HD), European journal of cancer, 33, 1997, pp. 1194-1194
RELATION BETWEEN IL-10 AND IL-12 SECRETION IN HODGKINS-DISEASE (HD)
Authors: VIVIANI S NOTTI P BONFANTE V CAMERINI E PARRA HS SANTORO A
Citation: S. Viviani et al., RELATION BETWEEN IL-10 AND IL-12 SECRETION IN HODGKINS-DISEASE (HD), European journal of cancer, 33, 1997, pp. 1225-1225
A NEW STAGING SYSTEM FOR SMALL-CELL LUNG-CANCER (SCLC) - A PROPOSAL
Authors: SANTORO A PARRA HS BIDOLI P SALVINI PM ANGELIDOU M CATALDO I VALAGUSSA P BONADONNA G
Citation: A. Santoro et al., A NEW STAGING SYSTEM FOR SMALL-CELL LUNG-CANCER (SCLC) - A PROPOSAL, European journal of cancer, 31A, 1995, pp. 93-93
CHEMOTHERAPY (CT) WITH RADIOTHERAPY (RT) - LARYNX PRESERVATION STRATEGY IN CERVICAL SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS (CSCCE)
Authors: BIDOLI P PARRA HS SANTORO A VALENTE M CANTU G ZUCALI R RAVASI G BONADONNA G
Citation: P. Bidoli et al., CHEMOTHERAPY (CT) WITH RADIOTHERAPY (RT) - LARYNX PRESERVATION STRATEGY IN CERVICAL SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS (CSCCE), European journal of cancer, 31A, 1995, pp. 398-398
CHEMOTHERAPY (CT) WITH RADIOTHERAPY (RT) - LARYNX PRESERVATION STRATEGY IN CERVICAL SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS (CSCCE)
Authors: BIDOLI P PARRA HS SANTORO A VALENTE M CANTU G ZUCALI R RAVASI G BONADONNA G
Citation: P. Bidoli et al., CHEMOTHERAPY (CT) WITH RADIOTHERAPY (RT) - LARYNX PRESERVATION STRATEGY IN CERVICAL SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS (CSCCE), European journal of cancer, 31A, 1995, pp. 398-398
SECOND MALIGNANCIES (SM) IN ESOPHAGEAL CANCER (EC) AFTER COMBINED-MODALITY TREATMENT - IMPLICATIONS FOR FOLLOW-UP AND CHEMOPREVENTION
Authors: PARRA HS SANTORO A BIDOLI P SALVINI PM ANTONELLI G BONADONNA G
Citation: Hs. Parra et al., SECOND MALIGNANCIES (SM) IN ESOPHAGEAL CANCER (EC) AFTER COMBINED-MODALITY TREATMENT - IMPLICATIONS FOR FOLLOW-UP AND CHEMOPREVENTION, European journal of cancer, 31A, 1995, pp. 545-545
ONDANSETRON VERSUS GRANISETRON, BOTH COMBINED WITH DEXAMETHASONE, IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS
Authors: BASURTO C CICCARESE G PALLADINO MA PICCIAFUOCO M RICCI S ANTONUZZO A ALLEGRINI G CONTE PF COGNETTI F CIRULLI S COLELLA E MILELLA M SAVARESE A STANI S CONTU A OLMEO N PIRO S PIRAS M PILO L PILO P NUZZO A URSINI LA TARABORRELLI M MELENA S BASILICO L BUZZI F BRUGIA M TRIPPA F DELRIO S TAGLIAVENTI M PICECE V CASSANDRINI P CIRILLO M MAGAROTTO R RECALDIN E CLERICO M BARTETTO O MORANDINI MP BAINOTTI L BONI C MORETTI G SAVOLDI L TATEO S CHIAPPARINI I ZARA C CATALANO G CASCINU S ALESSANDRONI P MASSIDDA B IONTA MT PEDDITZI E MONTINARI F CASARTELLI C MANDELLI D ROTONDO SG LELLI G CILENTI G MORRITTI M PUSCEDDU G SALARIS G PRESTI ML FAVALLI G GAMBINO A RAVELLI V CORTESI E GIOACCHINI N OLIVA A DAZZI C MONTANARI L CRUCIANI G DEMARINIS F SCARFONE G BOLIS MC SCAGLIOTTI G SELVAGGI G DONATI D MALACARNE P SANTORO A PARRA HS LOCATELLI MC LUPORINI G SANSONI E MATERA G FAVA C
Citation: C. Basurto et al., ONDANSETRON VERSUS GRANISETRON, BOTH COMBINED WITH DEXAMETHASONE, IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS, Annals of oncology, 6(8), 1995, pp. 805-810
A SUMMARY OF THE MILAN EXPERIENCE WITH MULTIMODALITY THERAPIES IN PATIENTS WITH SMALL-CELL LUNG-CANCER - ATTEMPTS TO IMPROVE LONG-TERM OUTCOME
Authors: SANTORO A PARRA HS BIDOLI P ANGELIDOU M CATALDO I SALVINI P VALAGUSSA P MILANI F RAVASI G BENADONNA G
Citation: A. Santoro et al., A SUMMARY OF THE MILAN EXPERIENCE WITH MULTIMODALITY THERAPIES IN PATIENTS WITH SMALL-CELL LUNG-CANCER - ATTEMPTS TO IMPROVE LONG-TERM OUTCOME, Seminars in oncology, 22(1), 1995, pp. 9-14
Risultati: 1-11 |